Home › SEC Filings › Insider Cluster Activity
Insider Cluster Activity
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| LXEO | CLUSTER | neutral | 2/10 | Two LXEO insiders, CEO and COO, sold a combined $24K in open-market sales on the same day, 9 days after Q1 2026 earnings | May 20, 2026 |
| REPL | CLUSTER | neutral | 4/10 | Three REPL insiders (CEO, CFO, and a director) sold a total of $319K in open-market sales on May 18, 2026, all at $5.08 | May 20, 2026 |
| CYTK | CLUSTER | neutral | 3/10 | CEO Robert Blum and EVP Fady Malik sold a total of $849K in open-market transactions within a week of a $700M equity off | May 20, 2026 |
| MTEX | CLUSTER | bullish | 6/10 | Two directors purchased a total of $51K in open-market shares, representing 0.64% of the $8M market cap. This follows a | May 20, 2026 |
| ARTV | CLUSTER | bearish | 5/10 | CEO Fred Aslan and CMO Subhashis Banerjee sold a combined $308K in open-market sales on May 19, 2026, just 11 days after | May 19, 2026 |
| TNYA | CLUSTER | neutral | 2/10 | Two Tenaya insiders (CMO and SVP Finance) sold a combined $3.7K worth of shares on May 18, 2026, all at ~$0.79 per share | May 19, 2026 |
| EXEL | CLUSTER | neutral | 3/10 | Exelixis CFO and General Counsel sold a combined ~$2.08M in open-market shares on May 18, 2026, alongside a large non-ca | May 19, 2026 |
| PHVS | CLUSTER | neutral | 4/10 | Two C-suite insiders at Pharvaris sold a combined $560K in open-market sales on May 15, 2026, just 11 days after the com | May 19, 2026 |
| PCSA | CLUSTER | bullish | 5/10 | Four C-suite insiders at Processa Pharmaceuticals (PCSA) collectively purchased $19K worth of shares on May 15, 2026, at | May 19, 2026 |
| PCSA | CLUSTER | bullish | 5/10 | Six PCSA insiders, including the CEO, CFO, and four other C-suite officers, made clustered open-market purchases totalin | May 19, 2026 |
| PTCT | CLUSTER | neutral | 2/10 | Two insiders at PTC Therapeutics sold a combined $220K of stock shortly after a strong Q1 earnings beat and raised guida | May 19, 2026 |
| ACOG | CLUSTER | bullish | 5/10 | Two insiders at Alpha Cognition (ACOG) made open-market purchases totaling ~$119K over a 7-day window. The COO bought $2 | May 19, 2026 |
| ELAN | CLUSTER | bullish | 5/10 | CEO Jeffrey Simmons and executive Rajeev Modi made open-market purchases totaling ~$200K on May 15, 2026, just 9 days af | May 19, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | UTHR's CEO, CFO, and a director sold shares worth $271K in aggregate over a week following Q1 2026 earnings that showed | May 19, 2026 |
| BBIO | CLUSTER | neutral | 3/10 | A cluster of insider selling at BridgeBio Pharma (BBIO) occurred in the week following the Q1 2026 earnings release and | May 19, 2026 |
| ZLAB | CLUSTER | bearish | 6/10 | CEO Du Ying sold $3.3M worth of ZLAB shares over a 5-day window, primarily through same-day option exercises and open-ma | May 19, 2026 |
| BCRX | CLUSTER | neutral | 3/10 | Two BioCryst insiders sold a total of $697K in open-market sales within a week of Q1 2026 earnings. The CLO exercised 62 | May 19, 2026 |
| VRTX | CLUSTER | neutral | 2/10 | Two EVP-level insiders at Vertex (CMO and Chief Scientific Officer) sold open-market shares on the same day for a combin | May 19, 2026 |
| MCRB | CLUSTER | neutral | 2/10 | Four corporate officers and one director sold a total of 474 shares for ~$3,569 in open-market transactions on May 18, 2 | May 19, 2026 |
| KALV | CLUSTER | neutral | 2/10 | Two C-suite insiders, the CEO and CMO of KalVista, made nominal open-market sales totaling $58K (-0.004% of $1.4B market | May 19, 2026 |
| HROW | CLUSTER | bullish | 7/10 | Harrow CEO Mark Baum, CFO Andrew Boll, and two directors collectively purchased $438K of stock in a 7-day cluster follow | May 19, 2026 |
| MPLT | CLUSTER | bearish | 5/10 | CEO Christopher Kroeger sold $3.21M of MPLT stock on May 18, four days after the company reported Q1 2026 results (net l | May 18, 2026 |
| UTHR | CLUSTER | neutral | 2/10 | CEO Martine Rothblatt, CFO James Edgemond, and Director Nilda Mesa sold a total of ~$1.03M in UTHR shares over the past | May 18, 2026 |
| ORKA | CLUSTER | neutral | 3/10 | Two senior insiders at Oruka Therapeutics (CMO & SVP Finance) collectively sold ~$540K of stock on May 15-18, 2026, foll | May 18, 2026 |
| NBIX | CLUSTER | neutral | 3/10 | Two NBIX directors sold $2.96M in shares over a 4-day window, representing a trivial 0.019% of market cap. Sales occurre | May 18, 2026 |
| MAZE | CLUSTER | neutral | 3/10 | CEO Jason Coloma and President/CMO Harold Bernstein sold a combined $441K in open-market shares within days of Maze Ther | May 18, 2026 |
| COLL | CLUSTER | neutral | 3/10 | Two directors at Collegium Pharmaceutical sold a combined $485K in open-market stock within 11 days of the company repor | May 18, 2026 |
| TEVA | CLUSTER | neutral | 2/10 | TEVA insiders sold $5.66M in stock on May 14, 2026, led by CFO Eliyahu Sharon Kalif ($5.46M). The sales occurred at ~$35 | May 18, 2026 |
| STTK | CLUSTER | neutral | 3/10 | Two STTK insiders (CMO and CTO) sold a combined $212K in open-market sales on May 12, 2026, following the Q1 earnings re | May 18, 2026 |
| APGE | CLUSTER | neutral | 3/10 | CEO Michael Thomas Henderson sold $1.53M worth of APGE stock on May 13, 2026, and CMO Carl Dambkowski sold $311K on May | May 15, 2026 |